Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)
This grant renews the NIH REACH program to seed academic entrepreneurship hubs that accelerate translation of biomedical discoveries. The hubs will provide innovators with initial investment, mentorship, and resources for proof-of-concept work, product definition studies, and early-stage technology development, while building infrastructure and partnerships for commercialization.
Key facts
Update history